TNFRSF12A and neoplasm: To redirect either RevCAR-E5B9 or RevCAR-E7B6 T or the respective RevCAR NK-92 cells against Fn14-expressing GBM tumor cells, we developed two Fn14-specific RevTMs, namely Fn14-5B9 and Fn14-7B6 (Fig. 1A, B).